Published in J Oncol on December 15, 2010
Age at diagnosis of female breast cancer in Oman: Issues and implications. South Asian J Cancer (2014) 0.92
BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African. Dis Markers (2015) 0.87
Vitamin D status and breast cancer in Saudi Arabian women: case-control study. Am J Clin Nutr (2013) 0.87
Human papillomavirus infection and risk of breast cancer: a meta-analysis of case-control studies. Infect Agent Cancer (2016) 0.82
Presence of human papillomavirus in breast cancer and its association with prognostic factors. Ecancermedicalscience (2015) 0.80
Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis. PLoS Med (2016) 0.75
Cognizance and utilization about breast cancer screening among the health professional female students and staffs of University Kuala Lumpur, Royal College of Medicine Perak, Malaysia. Indian J Med Paediatr Oncol (2017) 0.75
Highlights and conclusions from the Eastern Mediterranean Public Health Network (EMPHNET) conference 2011. East Mediterr Health J (2012) 0.75
Socio-demographic and clinical profile of immuno-histochemically confirmed breast cancer in a resource limited country. Pan Afr Med J (2014) 0.75
A systematic review of yoga interventions as integrative treatment in breast cancer. J Cancer Res Clin Oncol (2016) 0.75
Women Experiences of Using External Breast Prosthesis after Mastectomy. Asia Pac J Oncol Nurs (2017) 0.75
Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol (2002) 6.51
Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol (2005) 3.01
"Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med (2008) 2.85
Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg (2006) 2.33
Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer (2008) 2.28
Effects of young age at presentation on survival in breast cancer. BMC Cancer (2006) 2.16
Breast cancer care in developing countries. World J Surg (2009) 1.91
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin (1997) 1.75
Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol (2001) 1.69
The outcome of treatment of breast cancer in a developing country--Oman. Breast (2004) 1.45
Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol (1999) 1.33
Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol (2004) 1.33
Breast cancer incidence in South Africa. J Clin Oncol (2001) 1.24
Breast cancer in developing countries. Lancet (2009) 1.16
Temporal trends in breast cancer presentation in the third world. J Exp Clin Cancer Res (2008) 1.09
Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer (2008) 1.07
Breast cancer in limited-resource countries: diagnosis and pathology. Breast J (2006) 1.05
[Breast cancer in Tunisia: clinical and epidemiological study]. Bull Cancer (1999) 1.05
Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg (2004) 1.03
First breast cancer mammography screening program in Mexico: initial results 2005-2006. Breast J (2009) 0.97
Research in action: mammography utilization following breast cancer awareness campaigns in Lebanon 2002-05. East Mediterr Health J (2009) 0.92
Effect of social class disparities on disease stage, quality of treatment and survival outcomes in breast cancer patients from developing countries. Breast J (2008) 0.88
Breast conservation in locally advanced breast cancer in developing countries: wise or waste. Surg Oncol (2008) 0.85
Guidelines for breast cancer screening in Lebanon Public Health Communication. J Med Liban (2009) 0.84
Current treatment modalities of breast-cancer patients in Alexandria, Egypt. Breast (2001) 0.83
Lack of awareness about breast cancer and its screening in developing countries. Indian J Cancer (2009) 0.81
Mammography in developing countries: the risks associated with globalizing the experiences of the Western world. Nat Clin Pract Oncol (2008) 0.81
Neoplastic diseases in Aleppo, Syria. Eur J Cancer Prev (2002) 0.79
The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication. Gastrointest Endosc (2007) 1.53
Inflammatory pseudo-tumor of the liver: a rare pathological entity. World J Surg Oncol (2011) 1.19
Update on totally implantable venous access devices. Surg Oncol (2012) 1.17
Isolated splenic metastasis from colorectal cancer. Int J Clin Oncol (2011) 1.16
Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics. Cancer Metastasis Rev (2014) 1.11
Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab (2005) 1.07
Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer. Crit Rev Oncol Hematol (2012) 1.02
Risk factors for pulmonary hypertension in patients with β thalassemia intermedia. Eur J Intern Med (2011) 1.01
Loss of CD20 expression in relapsed lymphomas after rituximab therapy. Eur J Haematol (2003) 0.98
Primary undifferentiated embryonal sarcoma of the liver mistaken for hydatid disease. World J Surg Oncol (2010) 0.98
Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Popul Health Metr (2014) 0.97
Unusually young age distribution of primary hepatic leiomyosarcoma: case series and review of the adult literature. World J Surg Oncol (2010) 0.97
Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis. BMC Urol (2014) 0.93
Angiogenesis and anti-angiogenic therapy in prostate cancer. Crit Rev Oncol Hematol (2013) 0.93
Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication? Hemoglobin (2002) 0.92
A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer. Radiat Oncol (2010) 0.90
Potential targets for colorectal cancer prevention. Int J Mol Sci (2013) 0.89
Maxillary Sinus Squamous Cell Carcinoma Presenting with Fatal Tumor Lysis Syndrome: A Case Report and Review of the Literature. Case Rep Oncol (2009) 0.89
Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing. Lancet Oncol (2004) 0.89
Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice? World J Surg Oncol (2013) 0.88
The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome. Transfus Apher Sci (2005) 0.87
Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women. Mutat Res (2013) 0.86
Crosstalk between HER2 signaling and angiogenesis in breast cancer: molecular basis, clinical applications and challenges. Curr Opin Oncol (2013) 0.86
Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East. World J Surg Oncol (2012) 0.85
High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon. Thromb Haemost (2003) 0.83
Peri-ampullary mixed acinar-endocrine carcinoma. Rare Tumors (2011) 0.83
Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I. Blood (2006) 0.82
Aspirin Has a Protective Effect Against Adverse Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding. Dig Dis Sci (2015) 0.82
Successful one stage operation for a synchronous, duodenal carcinoma, colonic carcinoma and renal oncocytoma in an adult patient. World J Surg Oncol (2011) 0.82
New treatment developments applied to elderly patients with advanced prostate cancer. Cancer Treat Rev (2013) 0.82
A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer. Clin Breast Cancer (2011) 0.81
Survey of utilization of multidisciplinary management tumor boards in Arab countries. Breast (2011) 0.79
Thrombotic thrombocytopenic purpura in a patient with Behçet's disease. Arthritis Rheum (2003) 0.79
Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient. BMJ Case Rep (2013) 0.79
Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome. Int J Radiat Oncol Biol Phys (2007) 0.79
Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia. Am J Hematol (2004) 0.78
Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma. Gastrointest Cancer Res (2012) 0.78
A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis. Gastrointest Cancer Res (2013) 0.78
Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region. J Natl Compr Canc Netw (2010) 0.77
Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura. Hemoglobin (2002) 0.77
Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia. Expert Rev Hematol (2013) 0.77
Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation: Two-Center Experience. Transplantation (2017) 0.76
Polydimethylsiloxane: An effective immune adjuvant and slow-release cytokine medium for local cancer treatment. J Carcinog (2008) 0.76
Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20. Hematol J (2003) 0.76
A young woman with liver cancer. Gastrointest Cancer Res (2013) 0.76
Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center. Transfusion (2003) 0.75
Gaucher disease: different clinical manifestations associated with a rare mutation (R48W) in a Lebanese family. Mol Genet Metab (2007) 0.75
Thalidomide-associated gynecomasty in a patient with multiple myeloma. Hematol J (2003) 0.75
Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome. Gastrointest Cancer Res (2013) 0.75
A 72-year-old man with duodenal adenocarcinoma. Gastrointest Cancer Res (2012) 0.75
A case of advanced gastric cancer. Gastrointest Cancer Res (2012) 0.75
Hepatocellular carcinoma following renal transplantation. Gastrointest Cancer Res (2011) 0.75
Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer. Gastrointest Cancer Res (2013) 0.75
Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma. Gastrointest Cancer Res (2012) 0.75
A 71-year-old man with a large cystic pancreatic mass. Gastrointest Cancer Res (2012) 0.75
Management of a locally advanced rectal cancer in a patient who declined surgery. Gastrointest Cancer Res (2012) 0.75
The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers. Nucl Med Commun (2016) 0.75
New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer. Curr Drug Targets (2016) 0.75
The elusive diagnosis of primary esophageal lymphoma. Turk J Haematol (2017) 0.75
Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis Asian Pac J Cancer Prev (2017) 0.75
Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor. J Gastrointest Cancer (2011) 0.75
Moyamoya syndrome with intraventricular hemorrhage in an adult with factor V Leiden mutation. Arch Neurol (2005) 0.75
The value of inhibitors of factor Xa for the treatment of pulmonary embolism. Intern Emerg Med (2014) 0.75
A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management. J Gastrointest Cancer (2012) 0.75
Modified GTX as second-line therapy for advanced pancreatic adenocarcinoma. J Gastrointest Cancer (2014) 0.75
Gastrointestinal cancer educatinal case series: a 65 year-old female with locally advanced gastric cancer and a supraclavicular lymph node. J Gastrointest Cancer (2012) 0.75
A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management. J Gastrointest Cancer (2011) 0.75
Hb H disease and multiple myeloma. Hemoglobin (2004) 0.75
Report of a rare co-incidence of congenital factor V deficiency and thalassemia intermedia in a family. Ann Saudi Med (2004) 0.75
Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center. Int J Radiat Oncol Biol Phys (2005) 0.75
Anxiety, Depression and Quality of Life in Breast Cancer Patients in the Levant Asian Pac J Cancer Prev (2017) 0.75
B-type proto-oncogene-mutated tumors of colon cancer: promising therapeutic approaches. Curr Opin Oncol (2015) 0.75
Late-onset hypogonadism: an undertreated condition in aging Lebanese men. J Med Liban (2013) 0.75
Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population Asian Pac J Cancer Prev (2017) 0.75
Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer. Breast (2004) 0.75
Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody. Ann Hematol (2003) 0.75
Gastrointestinal cancer educational case series: the history and management of complex cases in gi oncology. A 72 year-old man with metastatic gastric cancer. J Gastrointest Cancer (2011) 0.75
Adenocarcinoma of the lung presenting as a metastatic tongue mass. South Med J (2008) 0.75